We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Protherics | LSE:PTI | London | Ordinary Share | GB0007029209 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 45.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
18/9/2008 07:28 | A sad end but no surprise in this market. | superbarnet | |
18/9/2008 07:14 | Well you can see the logic in the deal, but obviously it is a disappointment as its not cash, its 60p and its BTG. | red ninja | |
18/9/2008 07:09 | a very bad deal, sold out! is it really worth it? i guess we still have an interest in the pipeline! | martinfrench | |
18/9/2008 07:07 | "price of 60 pence for each Protherics Share" Look where the price went - 58p! Look which name was touted - BTG Such a clear flouting of insider rules. Will the FSA look into it? Will they f! | the_doctor | |
17/9/2008 22:53 | bobby.ifa Famous last words. Still banks cannot keep going to the wall at the current rate and maybe there will be news tomorrow ..... | red ninja | |
16/9/2008 12:55 | Interesting to see the share price hold up while this market capitulates. | bobby.ifa | |
16/9/2008 12:46 | Program on Radio 4 last evening discussing use of anti alpha TNF drugs ( anti-inflammatories) in treatment of heart disease and cancers, in conjuction with 'traditional' treatments for those conditions. Is there anything in PTI technology,which might strike a chord in this area - angiotensin or cytofab interfering with the bodies panic mechanisms? Expert comment welcomed. | fhmktg | |
15/9/2008 16:31 | All these companies going bust are those with funding problems. If you need to raise cash to keep your company going in this market then you are in deep sh*t. One thing about PTI is that it does not need to raise cash at the moment and it has an increasing income stream going into the future. So long as it is able to keep expenditure in line with this then it shouldn't have a problem. As long as the board have enough faith in the pipeline we should see any silly bids rejected outright. Keep the faith. HT. | hot_topic | |
15/9/2008 13:25 | Superbarnet- this market worries me that we could be sold at a knock down price and the hope of #1.00 diminshes daily. | bobby.ifa | |
15/9/2008 13:05 | I imagine nobody is wanting to commit any serious expenditure in this nervous trading. | superbarnet | |
15/9/2008 12:59 | Mmm, sure a deal could still be the outcome from the approches by a number of parties. Its just the longer we go on without news the more likely that some nervous investors will be to sell or pare down their holdings. | red ninja | |
12/9/2008 16:17 | The advice is never try to catch a falling knife. Increased volume will be a sign of some news. | superbarnet | |
12/9/2008 15:28 | Ouch, drop and into auction. Would normally have said news leaking but could just be stop losses triggering. If the former then probably another RNS from directors later. | devbod | |
12/9/2008 15:28 | 10% drop today so far seems ominous!! | mre | |
12/9/2008 13:39 | Volume is very low tho and the share price seems to react to small trades. Implies to me that no one knows whats going on and that the odd 'bird in the hand rather than the bush' shareholder is taking profits. At least the prolonged silence implies the directors think the current talks are worth having. | devbod | |
12/9/2008 13:26 | The current weakness appears to suggest action is not imminent. | superbarnet | |
12/9/2008 12:41 | bobby.ifa --- I fully agree with that. JB | baronet 1 | |
12/9/2008 12:32 | I wish the share price refected its true value. | bobby.ifa | |
12/9/2008 12:00 | I certainly wouldnt be happy with a cash offer near the current share price In that instance I'd much prefer talks were called off, take the short term share price hit and see what the result of the cytofab phase II trial brings. No matter what happens we're a lot better of than we were a month ago. Multiple bidders gives independent confirmation that there is a bright future for PTI. | devbod | |
12/9/2008 11:32 | WAY THINGS ARE GOING THE OUTCOME IS ALREADY KNOWN......THE WAIT AND THE CONJECTURE IS VERY DEPRESSING, BUT THINK 35-40P WILL BE THE FALLBACK PRICE IF NO BIDS ARE FORTHCOMING. | martinfrench | |
12/9/2008 10:30 | The FSA would have something to say about such a scheme. My bet is on AZN and GSK taking a look at the underlying technology behind CytoFab, DigiFab and Angiotensin as part of their longer term protein fragment portfolios and wanting to get their hands on both the science/products and manufacturing expertise. If it is one or more of the majors, I would expect to see a real auction going on, behind the scenes - the valuation being preared by to IP lawyer could be crucial - cancer portfolio notwithstanding. If all goes well over the coming three months I would hope for an outcome significantly higher than today's share price - with £1.50 not being out of court. | fhmktg | |
12/9/2008 10:18 | What about this for an idea. The board have made it all up so AZ have had to show if they are interested, now the board know if AZ are seious about CYTOFAB the share price has had a bit of a spike and all is good. I know it's a long shot but in the few years i've had shares a board doing this would not supprise me at all. | golly1980 | |
11/9/2008 15:59 | My theory has always been that it was probably more than one bidder - in line with the RNS. Just potentially initiated by a cheeky bidder. I'd call two "a number of parties", but who knows hey!? | the_doctor | |
11/9/2008 15:57 | Doc In my book "a number of parties" is more than two....but at least you have raised it from your "cheeky approach" theory, which implied only one bidder. | kmjs |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions